E. Aubrey Thompson

13.8k total citations
112 papers, 5.0k citations indexed

About

E. Aubrey Thompson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, E. Aubrey Thompson has authored 112 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 49 papers in Oncology and 37 papers in Cancer Research. Recurrent topics in E. Aubrey Thompson's work include HER2/EGFR in Cancer Research (18 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Immunotherapy and Biomarkers (14 papers). E. Aubrey Thompson is often cited by papers focused on HER2/EGFR in Cancer Research (18 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Immunotherapy and Biomarkers (14 papers). E. Aubrey Thompson collaborates with scholars based in United States, Canada and Finland. E. Aubrey Thompson's co-authors include Alan P. Fields, Brian M. Necela, Edith A. Perez, David Reisman, Selina Glaros, Yan W. Asmann, Tien C. Ko, Weidong Su, Nicole R. Murray and Lee Jamieson and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

E. Aubrey Thompson

109 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Aubrey Thompson United States	42	3.3k	1.6k	1.2k	504	486	112	5.0k
Maréne Landström Sweden	32	3.2k 1.0×	1.3k 0.8×	1.0k 0.8×	493 1.0×	553 1.1×	81	4.7k
Youyong Lu China	35	2.8k 0.9×	1.4k 0.9×	1.5k 1.3×	358 0.7×	443 0.9×	122	4.4k
Gustavo Baldassarre Italy	40	3.4k 1.1×	1.6k 1.0×	1.8k 1.5×	432 0.9×	449 0.9×	134	5.1k
Melanie Boerries Germany	38	2.8k 0.9×	1.3k 0.8×	1.0k 0.9×	572 1.1×	390 0.8×	164	4.5k
Remond J.A. Fijneman Netherlands	36	2.0k 0.6×	1.3k 0.8×	1.2k 1.0×	619 1.2×	556 1.1×	130	4.1k
Giovanna Chiorino Italy	37	3.0k 0.9×	1.3k 0.9×	1.3k 1.0×	578 1.1×	532 1.1×	113	4.8k
Song Liu United States	41	2.9k 0.9×	1.3k 0.8×	1.4k 1.2×	821 1.6×	478 1.0×	167	4.9k
Cristina Peña Spain	37	3.5k 1.1×	1.9k 1.2×	2.1k 1.7×	516 1.0×	479 1.0×	73	5.4k
Lu‐Hai Wang United States	39	3.1k 1.0×	1.4k 0.9×	1.1k 0.9×	536 1.1×	410 0.8×	87	4.6k
Jiong Deng China	30	3.3k 1.0×	2.0k 1.3×	1.2k 1.0×	644 1.3×	469 1.0×	61	4.8k

Countries citing papers authored by E. Aubrey Thompson

Since Specialization

Citations

This map shows the geographic impact of E. Aubrey Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Aubrey Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Aubrey Thompson more than expected).

Fields of papers citing papers by E. Aubrey Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Aubrey Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Aubrey Thompson. The network helps show where E. Aubrey Thompson may publish in the future.

Co-authorship network of co-authors of E. Aubrey Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of E. Aubrey Thompson. A scholar is included among the top collaborators of E. Aubrey Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Aubrey Thompson. E. Aubrey Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xue, Vivekananda Sarangi, Daniel P. Wickland, et al.. (2024). Identification of gene regulatory networks associated with breast cancer patient survival using an interpretable deep neural network model. Expert Systems with Applications. 262. 125632–125632. 1 indexed citations

Bastea, Ligia I., Xiang Liu, Veethika Pandey, et al.. (2024). Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer. Nature Communications. 15(1). 10547–10547. 2 indexed citations

Carter, Jodi M., Mei‐Yin C. Polley, Roberto A. Leon‐Ferre, et al.. (2021). Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer. Clinical Cancer Research. 27(20). 5628–5637. 35 indexed citations

Caparica, Rafael, Claudia De Angelis, François Richard, et al.. (2021). Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial. Clinical Breast Cancer. 22(4). 308–318. 4 indexed citations

Asleh, Karama, Heather Ann Brauer, Amy Sullivan, et al.. (2020). Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial. Clinical Cancer Research. 26(11). 2603–2614. 20 indexed citations

Chumsri, Saranya, Daniel Serie, Zhuo Li, et al.. (2019). Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials. Clinical Cancer Research. 25(14). 4422–4430. 5 indexed citations

Chumsri, Saranya, Zhuo Li, Daniel Serie, et al.. (2019). Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31. Journal of Clinical Oncology. 37(35). 3425–3435. 50 indexed citations

Perez, Edith A., Karla V. Ballman, Afshin Mashadi-Hossein, et al.. (2016). Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial. JNCI Journal of the National Cancer Institute. 109(2). djw207–djw207. 27 indexed citations

Borgés, Sahra, Edith A. Perez, E. Aubrey Thompson, et al.. (2015). Effective Targeting of Estrogen Receptor–Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101. Molecular Cancer Therapeutics. 14(6). 1306–1316. 51 indexed citations

10.

Perez, Edith A., Frederick L. Baehner, Steven M. Butler, et al.. (2015). The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831. Breast Cancer Research. 17(1). 133–133. 17 indexed citations

11.

Perez, Edith A., E. Aubrey Thompson, Karla V. Ballman, et al.. (2015). Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial. Journal of Clinical Oncology. 33(7). 701–708. 144 indexed citations

12.

Perez, Edith A., E. Aubrey Thompson, S. Keith Anderson, et al.. (2014). Association of genomic analysis of immune function genes and clinical outcome in the NCCTG (Alliance) N9831 adjuvant trastuzumab trial.. Journal of Clinical Oncology. 32(15_suppl). 509–509. 9 indexed citations

13.

Joseph, Richard W., Mansi Parasramka, Jeanette E. Eckel‐Passow, et al.. (2013). Inverse Association between Programmed Death Ligand 1 and Genes in the VEGF Pathway in Primary Clear Cell Renal Cell Carcinoma. Cancer Immunology Research. 1(6). 378–385. 31 indexed citations

14.

Asmann, Yan W., Brian M. Necela, Krishna R. Kalari, et al.. (2012). Detection of Redundant Fusion Transcripts as Biomarkers or Disease-Specific Therapeutic Targets in Breast Cancer. Cancer Research. 72(8). 1921–1928. 75 indexed citations

15.

Asmann, Yan W., Asif Hossain, Brian M. Necela, et al.. (2011). A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Research. 39(15). e100–e100. 80 indexed citations

16.

Andorfer, Cathy, Brian M. Necela, E. Aubrey Thompson, & Edith A. Perez. (2011). MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. Trends in Molecular Medicine. 17(6). 313–319. 168 indexed citations

17.

Regala, Roderick P., E. Aubrey Thompson, & Alan P. Fields. (2008). Atypical Protein Kinase Cι Expression and Aurothiomalate Sensitivity in Human Lung Cancer Cells. Cancer Research. 68(14). 5888–5895. 76 indexed citations

18.

Necela, Brian M. & E. Aubrey Thompson. (2008). Pathophysiological Roles of PPARγ in Gastrointestinal Epithelial Cells. PPAR Research. 2008(1). 148687–148687. 7 indexed citations

19.

Yu, Wangsheng, Nicole R. Murray, Capella Weems, et al.. (2003). Role of Cyclooxygenase 2 in Protein Kinase C βII-mediated Colon Carcinogenesis. Journal of Biological Chemistry. 278(13). 11167–11174. 65 indexed citations

20.

Bishop, D. Timothy, E. Aubrey Thompson, & D. C. Rao. (1988). Linkage information and bias in the presence of interference. Genetic Epidemiology. 5(2). 107–119. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact